Suivre
Benjamin M. Greenberg
Benjamin M. Greenberg
Adresse e-mail validée de utsouthwestern.edu
Titre
Citée par
Citée par
Année
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
DM Wingerchuk, B Banwell, JL Bennett, P Cabre, W Carroll, T Chitnis, ...
Neurology 85 (2), 177-189, 2015
33622015
Genetic progression model for head and neck cancer: implications for field cancerization
J Califano, P Van Der Riet, W Westra, H Nawroz, G Clayman, ...
Cancer research 56 (11), 2488-2492, 1996
17911996
The varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic features
MA Nagel, RJ Cohrs, R Mahalingam, MC Wellish, B Forghani, A Schiller, ...
Neurology 70 (11), 853-860, 2008
5262008
Trial of satralizumab in neuromyelitis optica spectrum disorder
T Yamamura, I Kleiter, K Fujihara, J Palace, B Greenberg, ...
New England Journal of Medicine 381 (22), 2114-2124, 2019
3372019
Epidemiology of neuromyelitis optica in the United States: a multicenter analysis
MA Mealy, DM Wingerchuk, BM Greenberg, M Levy
Archives of neurology 69 (9), 1176-1180, 2012
3142012
Comparison of relapse and treatment failure rates among patients with neuromyelitis optica: multicenter study of treatment efficacy
MA Mealy, DM Wingerchuk, J Palace, BM Greenberg, M Levy
JAMA neurology 71 (3), 324-330, 2014
2932014
Neuromyelitis optica and multiple sclerosis: seeing differences through optical coherence tomography
JL Bennett, J De Seze, M Lana-Peixoto, J Palace, A Waldman, ...
Multiple Sclerosis Journal 21 (6), 678-688, 2015
2682015
Trial of fingolimod versus interferon beta-1a in pediatric multiple sclerosis
T Chitnis, DL Arnold, B Banwell, W Brück, A Ghezzi, G Giovannoni, ...
New England Journal of Medicine 379 (11), 1017-1027, 2018
2382018
Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trial
A Traboulsee, BM Greenberg, JL Bennett, L Szczechowski, E Fox, ...
The Lancet Neurology 19 (5), 402-412, 2020
2312020
Transverse myelitis
SC Beh, BM Greenberg, T Frohman, EM Frohman
Neurologic clinics 31 (1), 79-138, 2013
2002013
Current and emerging therapies in multiple sclerosis: a systematic review
W Castro-Borrero, D Graves, TC Frohman, AB Flores, P Hardeman, ...
Therapeutic advances in neurological disorders 5 (4), 205-220, 2012
1532012
Relationship of optic nerve and brain conventional and non-conventional MRI measures and retinal nerve fiber layer thickness, as assessed by OCT and GDx: a pilot study
EM Frohman, MG Dwyer, T Frohman, JL Cox, A Salter, BM Greenberg, ...
Journal of the neurological sciences 282 (1-2), 96-105, 2009
1532009
Evidence for a causal relationship between low vitamin D, high BMI, and pediatric-onset MS
MA Gianfrancesco, P Stridh, B Rhead, X Shao, E Xu, JS Graves, T Chitnis, ...
Neurology 88 (17), 1623-1629, 2017
1472017
Idiopathic transverse myelitis: corticosteroids, plasma exchange, or cyclophosphamide
BM Greenberg, KP Thomas, C Krishnan, AI Kaplin, PA Calabresi, DA Kerr
Neurology 68 (19), 1614-1617, 2007
1472007
Natalizumab and progressive multifocal leukoencephalopathy: what are the causal factors and can it be avoided?
C Warnke, T Menge, HP Hartung, MK Racke, PD Cravens, JL Bennett, ...
Archives of neurology 67 (8), 923-930, 2010
1362010
Memory B cells from a subset of treatment‐naïve relapsing‐remitting multiple sclerosis patients elicit CD4+ T‐cell proliferation and IFN‐γ production in response to …
CT Harp, S Ireland, LS Davis, G Remington, B Cassidy, PD Cravens, ...
European journal of immunology 40 (10), 2942-2956, 2010
1332010
Progressive multifocal leukoencephalopathy after fingolimod treatment
JR Berger, BA Cree, B Greenberg, B Hemmer, BJ Ward, VM Dong, ...
Neurology 90 (20), e1815-e1821, 2018
1302018
Area postrema syndrome: Frequency, criteria, and severity in AQP4-IgG–positive NMOSD
E Shosha, D Dubey, J Palace, I Nakashima, A Jacob, K Fujihara, ...
Neurology 91 (17), e1642-e1651, 2018
1182018
Rituximab dosing and monitoring strategies in neuromyelitis optica patients: creating strategies for therapeutic success
BM Greenberg, D Graves, G Remington, P Hardeman, M Mann, ...
Multiple Sclerosis Journal 18 (7), 1022-1026, 2012
1142012
Symptomatic therapy in multiple sclerosis
TC Frohman, W Castro, A Shah, A Courtney, J Ortstadt, SL Davis, ...
Therapeutic advances in neurological disorders 4 (2), 83-98, 2011
1112011
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20